Skip to main content
Premium Trial:

Request an Annual Quote

Alison Hannah, Lynn Tetrault

NeoGenomics announced the election of Alison Hannah and Lynn Tetrault to its board. Hannah has more than 25 years of experience in developing investigational cancer chemotherapies and has been a consultant to the pharma industry since 2000. She previously was senior medical director at Sugen. She will serve on NeoGenomics' compliance committee. 

Tetrault is a consultant to healthcare companies and is a director of Women's Way. She was at AstraZeneca between 1993 and 2014 and was most recently its executive vice president of HR and corporate affairs. She will chair NeoGenomics' nominating and governance committee and will be a member of the compensation committee. 

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.